Q2 2011 · —
Revenue$193.33M$193.33M +8.2% vs Q2 2010+6.8% vs Q1 2011
Net Income$699.00K$699.00K −95.4% vs Q2 2010−93.9% vs Q1 2011
EPS Diluted$0.02$0.02 −96.0% vs Q2 2010−94.7% vs Q1 2011
Gross Profit$120,491,000+5.6%
Operating Income$8,000,000−67.5%
Operating Cash Flowderived$24,583,000+27.0%
Free Cash Flowderived$17,367,000+27.6%
Margins · derived
Gross margin62.3%−1.6 pt vs Q2 2010
Operating margin4.1%−9.6 pt vs Q2 2010
Net margin0.4%−8.1 pt vs Q2 2010
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2011 | Q2 2010 | Q2 2009 |
|---|---|---|---|
| Revenue | $193.33M | $178.60M | $165.73M |
| Net Income | $699.00K | $15.16M | $11.23M |
| EPS Diluted | $0.02 | $0.50 | $0.38 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR